Clinical and Histopathologic Predictors of Survival Among Children With Retinoblastoma From Two Tertiary Health

Raymond Atwine1, Damaris Laffita2, Abraham Birungi1

  • 1Pathology, Mbarara University of Science and Technology, Mbarara, UGA.

Cureus
|January 16, 2024
PubMed

Insights

Retinoblastoma survival in Ugandan children is predicted by clinical signs like leukocoria and proptosis, along with factors such as optic nerve invasion and gender. Early detection and understanding these predictors are crucial for better patient outcomes.

Area of Science:

  • Ophthalmology
  • Pediatric Oncology
  • Pathology

Background:

  • Retinoblastoma (RB) is the most common pediatric intraocular cancer.
  • It originates from immature retinal cells and is curable.
  • Clinical and histological findings post-enucleation are vital for prognosis and secondary care.

Purpose of the Study:

  • To identify clinical and histopathological predictors of survival in children with retinoblastoma.
  • To analyze data from two tertiary health facilities in Uganda.

Main Methods:

  • Retrospective analysis of enucleated eye specimens (2014-2016).
  • Histopathological examination using hematoxylin and eosin staining to confirm RB, stage, and features.
  • Retrieval of clinical data including leukocoria, proptosis, and orbital extension.

Main Results:

  • The study included 78 children, with males (55.1%) predominating.
  • Leukocoria (69.2%) was the most common sign; Stage 1 was the most frequent histopathological stage (41%).
  • Optic nerve invasion (38.5%), choroidal invasion (29.5%), and orbital extension (16.7%) were observed. Two-year survival was 61.5%.
  • Significant survival predictors included leukocoria (RR 1.1), female gender (RR 1.4), intralaminar optic nerve invasion (RR 7.6), and lack of orbital extension (RR 7).

Conclusions:

  • Leukocoria and proptosis are key clinical indicators of retinoblastoma.
  • While many patients present at Stage 1, Stage 4 is also common.
  • Leukocoria, optic nerve invasion, orbital extension, and gender significantly predict survival in retinoblastoma patients.
Abstract